Coral Labs.

77
Buy
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE683E01017
  • NSEID:
  • BSEID: 524506
INR
680.10
16.35 (2.46%)
BSENSE

Nov 20

BSE+NSE Vol: 9.03 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is -25.31% vs 37.47% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is -42.02% vs 61.58% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 75.61% vs 48,700.00% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is -32.18% vs 52.99% in Mar 2025

Compare Profit and Loss Results of Coral Labs.
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
85.00
89.00
-4.00
-4.49%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
85.00
89.00
-4.00
-4.49%
Expenditure (Ex Depriciation)
Stock Adjustments
-6.00
-4.00
-2.00
-50.00%
Raw Materials Consumed
42.00
69.00
-27.00
-39.13%
Power & Fuel Cost
2.00
0.00
2.00
0%
Employee Cost
15.00
4.00
11.00
275.00%
Operating Expenses
4.00
1.00
3.00
300.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
1.00
0.00
1.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
6.00
0.00
6.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
70.00
74.00
-4.00
-5.41%
Operating Profit (PBDIT) excl Other Income
15.00
14.00
1.00
7.14%
Other Income
9.00
0.00
9.00
0%
Operating Profit (PBDIT)
25.00
15.00
10.00
66.67%
Interest
0.00
0.00
0.00
0%
Profit before Depriciation and Tax
24.00
14.00
10.00
71.43%
Depreciation
2.00
1.00
1.00
100.00%
Profit Before Taxation & Exceptional Items
22.00
13.00
9.00
69.23%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
23.00
13.00
10.00
76.92%
Provision for Tax
6.00
3.00
3.00
100.00%
Profit After Tax
16.00
9.00
7.00
77.78%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
170.00
7.00
163.00
2,328.57%
Profit Available for appropriations
187.00
16.00
171.00
1,068.75%
Appropriations
187.00
16.00
171.00
1,068.75%
Equity Dividend (%)
20%
0%
20.00
Earnings Per Share
45.85
9.03
36.82
407.75%
Profit And Loss - Net Sales
Net Sales 85.90 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -25.31% vs 37.47% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 15.21 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -42.02% vs 61.58% in Mar 2025

Profit And Loss - Interest
Interest 0.17 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 75.61% vs 48,700.00% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 16.38 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -32.18% vs 52.99% in Mar 2025